A cholesterol-lowering drug has been found to be effective in reducing the risk of stroke.
Lipitor, which is manufactured by Pfizer, is believed to reduce the risk of stroke by 17 per cent when compared to standard doses of other drugs.
The findings, presented to the World Congress of Cardiology in Barcelona, are based upon analysis of five separate clinical trials of the drug in comparison with other cholesterol-lowering drugs, as well as statins.
High doses of Lipitor were found to be slightly more effective in preventing strokes than low measurements of the drug.
Lipitor was also found to reduce the likelihood of a high-risk patient suffering a second heart attack by 46 per cent when compared to the use of the commonly prescribed drug simvastatin.
Of the 25,709 patients who took part in the trials, 2.77 per cent suffered a stroke during the 12 months following.